Varian Medical Systems and RaySearch Laboratories Sign Long-Term Collaboration Agreement to Develop Advanced Radiotherapy Treatment Planning.STOCKHOLM, Sweden -- Varian Medical Systems Varian Medical Systems (NYSE: VAR) is engaged in the design and manufacture of advanced equipment and software solutions for treating cancer with radiation, as well as x-ray tubes for original equipment manufacturers, replacement x-ray tubes and flat-panel digital subsystems and RaySearch Laboratories (STO:RAYB) have signed a long-term strategic collaboration agreement in which RaySearch will develop advanced radiation therapy treatment planning In radiotherapy, Treatment Planning is the process in which a team consisting of radiation oncologists, medical radiation physicists and dosimetrists plan the appropriate external beam radiotherapy treatment technique for a patient with cancer. Typically, medical imaging (i.e. software for integration into Varian's Eclipse[TM] treatment planning system. The collaboration involves developing a number of components, including radiobiological optimization software Free and Open Source software
n. The branch of radiology that deals with the use of ionizing radiation to treat cancers. radiation oncology treatments. "We are extremely excited about beginning a relationship with the world leader in radiotherapy treatment," says Johan Lof, president and chief executive officer of RaySearch. "The collaboration will permit us to offer a number of treatment planning solutions to Varian's large installed base of customers." Jeff Amacker, director of Varian's treatment planning software business, adds, "RaySearch has developed some truly innovative solutions for advanced radiation therapy planning and radiobiological optimization and we look forward to making these capabilities available to our Eclipse customers." Radiobiological optimization enables clinicians to use biological models such as probabilities relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc tumor control and normal tissue complication rates in different parts of the body, to optimize a treatment plan. This is different from more conventional approaches that use standard dose prescriptions, which are surrogates for outcomes, and less personalized to the patient's specific disease and anatomy. "Using biological models further enhances our ability to design treatments that eradicate the tumor while minimizing side effects Side effects Effects of a proposed project on other parts of the firm. ," says Johan Lof. The Varian-RaySearch collaboration agreement involves radiobiological evaluation and radiobiological optimization of treatment plans for standard photon/electron radiotherapy, intensity modulated radiation therapy (IMRT IMRT Intensity-modulated radiation therapy Radiation oncology A format for delivering high-dose RT to regions–eg, nasopharynx, that are surrounded by radiation-sensitive areas; in IMRT, a broad radiation field is divided into hundreds of small pencil beams, ) and proton therapy Proton therapy is a type of particle therapy which utilizes a beam of protons to irradiate a tumor site. Introduction Proton therapy is of interest because of its ability to accurately target and kill tumors, both near the surface and deep seated within the body, while , as well as optimization of conventional 3-D CRT (1) (C RunTime) See runtime library. (2) (Cathode Ray Tube) A vacuum tube used as a display screen in a computer monitor or TV. The viewing end of the tube is coated with phosphors, which emit light when struck by electrons. . The products will be seamlessly integrated into the Eclipse package. About Varian Medical Systems Varian Medical Systems, Inc., of Palo Alto, California “Palo Alto” redirects here. For other uses, see Palo Alto (disambiguation). Palo Alto (IPA: /ˌpæloʊˈʔæltoʊ/, from Spanish: palo: "stick" and alto: "high", i.e. , is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery radiosurgery /ra·dio·sur·gery/ (-ser´jer-e) surgery in which tissue destruction is performed by means of ionizing radiation rather than by surgical incision. , proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 3,900 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. In Europe, the company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA (Europe, Middle East, Africa) Refers to that region of the world. For example, one might see products packaged differently for the UK, EMEA and Asia Pacific markets. ) based in Zug, Switzerland. For more information, visit www.varian.com About RaySearch RaySearch's business concept is to provide innovative software to radiation therapy clinics for more effective radiation treatment of cancer. RaySearch, a spin-off from Karolinska Institutet, was formed in 2000. Through a licensing agreement with Philips, the company's first product, p-RayOptimizer, has to date been sold to approximately 1,000 hospitals internationally and more than 100,000 patients have received improved radiation therapy. A licensing agreement was signed with Nucletron at the beginning of 2004 and deliveries of the first product based on this partnership, n-RayOptimizer, began in April 2005. In February 2006 an agreement was signed with Scanditronix-Wellhofer regarding development of products for improved quality assurance of IMRT. In October 2006, RaySearch signed an agreement with Philips covering the development of products in adaptive radiation therapy. In November 2006 RaySearch signed a development and license agreement with Nucletron regarding treatment planning for proton therapy in cancer treatment. RaySearch is listed on the Nordic List in the Small Cap segment of the Health Care sector. RaySearch is based in Stockholm and currently has 30 employees. For more information, visit www.raysearchlabs.com This information was brought to you by Cision http://newsroom.cision.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion